GE HealthCare Technologies (GEHC) Common Equity (2022 - 2026)

GE HealthCare Technologies' Common Equity history runs 5 years deep, the most recent figure standing at $10.7 billion for Q1 2026.

• Quarterly Common Equity rose 15.87% year-over-year to $10.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 billion (up 15.87% YoY) and the FY2025 annual result came in at $10.4 billion, up 22.63% from the prior year.
• Common Equity was $10.7 billion for Q1 2026 at GE HealthCare Technologies, up from $10.4 billion in the prior quarter.
• Across five years, Common Equity topped out at $17.1 billion in Q2 2022 and bottomed at $6.7 billion in Q1 2023.
• A 5-year average of $10.0 billion and a median of $9.2 billion in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity slumped 59.61% — and 2025, when it climbed 24.51%.
• GE HealthCare Technologies' Common Equity stood at $9.4 billion in 2022, then declined by 23.68% to $7.1 billion in 2023, then gained by 18.46% to $8.5 billion in 2024, then grew by 22.63% to $10.4 billion in 2025, then rose by 2.78% to $10.7 billion in 2026.
• Business Quant data shows GEHC's Common Equity at $10.7 billion in Q1 2026, $10.4 billion in Q4 2025, and $10.0 billion in Q3 2025.